FDA is an active partner in the coronavirus disease (COVID-19) response, working closely with our government and public health partners across the U.S. Department of Health and Human Services, and with our international counterparts. Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last MCMi email update on August 19, 2020 include: Coronavirus (COVID-19) updates- August 25, 2020: Daily Roundup - FDA actions including updated information for consumers about unsafe hand sanitizers and an Abbreviated New Drug Application approval for an inhaler to treat bronchospasm (narrowing of the airways)
- August 25, 2020: FDA Insight podcast - Drug Shortages and COVID-19, plus listen to previous episodes
- August 23, 2020: FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID–19 Treatment, Another Achievement in Administration’s Fight Against Pandemic
- August 21, 2020: FDA revokes Emergency Use Authorization for protective barrier enclosures without negative pressure due to potential risks
- August 20, 2020: Remarks on FDA Leadership to Accelerate the Recovery from COVID-19 to the Alliance for Health Policy, from Anand Shah, MD, Deputy Commissioner for Medical and Scientific Affairs
- Also see the features and Emergency Use Authorization Updates below, and ongoing updates to the list of hand sanitizers consumers should not use at: www.fda.gov/handsanitizerlist
|
|
|
|
.png)
No hay comentarios:
Publicar un comentario